Publication | Open Access
High WT1 Expression After Induction Therapy Predicts High Risk of Relapse and Death in Pediatric Acute Myeloid Leukemia
162
Citations
34
References
2006
Year
WT1 quantification is an informative molecular marker for MRD in pediatric AML and is now performed as prospective analysis in ELAM02 protocol.
| Year | Citations | |
|---|---|---|
Page 1
Page 1